Abstract:In order to acquire rotavirus outer membrane VP4,VP7 and LTB recombinant expression fusion protein and investigate its antigenicity and feasibility as an engineering subunit vaccine of group A bovine rotavirus against calf diarrhea,VP4 and VP7 gene of rotavirus isolate CHLY and LTB from E.coli was cloned and four prokaryotic recombinant expression vectors(pET32a/VP7,pET32a/VP4,pET32a/VP7-LTB and pET32a/VP4-LTB) were constructed and expressed.The recombinant proteins were purified and vaccines were prepared by mixing the protein with Freund's adjuvant.Antigenicity and challenge protection assay of four recombinant proteins were analyzed by immunizing the vaccines on 10w female mice whom were raised with male mice,and the suckling mice whom giving birth to were challenge with 150ul 10-6.5/0.1mL TCID50CHLY isolates.BandScan software analysis result showed that the ratio of rVP7,rVP4,rVP7-LTB and rVP4-LTB to total protein expressed by BL21(DE3) were 35%,20%,30% and 18%,respectively.Statistical analysis of ten week female mice after immunity revealed that IgG antibody tilter of rVP4-LTB group was highest in the four group.The second one was rVP4 group, the third was rVP7-LTB group,and the forth was rVP7 group.The difference among the four experimental groups were not significant(P0.05),but the difference between experimental group and control group was most significant(P0.01).Challenging experiment of suckling mice showed that diarrhea ratio of immune group was 13.35%-23.8%,diarrhea duration time was 48h-72h,which was lower than control group.The diarrhea ratio was 100% and diarrhea duration time was 96h.Challenge protective ratio of four recombinant protein groups were 76.2%-86.7%,among which rVP7-LTB and rVP4-LTB group were a little higher than rVP7 and rVP4 group,but the difference was not significant(P0.05).The experiment illustrated that the four recombinant proteins had better immunogenicity and the neutralization antibody of immune female mice could pass to its offspring and provide protection against rotavirus.

Intragastric Administration of Lactobacillus Casei Expressing Bovine Rotavirus Vp7 Protein Induced Specific Antibody Production

Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice

Oral Vaccination of Mice Against Helicobacter Pylori with Recombinant Lactococcus Lactis Expressing Urease Subunit B.

Oral Vaccination with the Porcine Rotavirus VP4 Outer Capsid Protein Expressed Bylactococcus Lactisinduces Specific Antibody Production

Construction of Recombinant Lactobacillus Casei Efficiently Surface Displayed and Secreted Porcine Parvovirus VP2 Protein and Comparison of the Immune Responses Induced by Oral Immunization

Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine parvovirus VP2 protein.

Recombinant Lactobacillus plantarum NC8 strain expressing porcine rotavirus VP7 induces specific antibodies in BALB/c mice

Directed chromosomal integration and expression of porcine rotavirus outer capsid protein VP4 in Lactobacillus casei ATCC393

The construction of recombinant Lactobacillus casei expressing BVDV E2 protein and its immune response in mice

Directed chromosomal integration and expression of porcine rotavirus outer capsid protein VP 4 in Lactobacillus casei ATCC393

Lactobacillus acidophilus Expressing Murine Rotavirus VP8 and Mucosal Adjuvants Induce Virus-Specific Immune Responses

Auxotrophic <i>Lactobacillus</i> Expressing Porcine Rotavirus VP4 Constructed Using CRISPR-Cas9D10A System Induces Effective Immunity in Mice

Immunogenicity evaluation of recombinant<i>Lactobacillus casei</i>W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant

Auxotrophic Lactobacillus Expressing Porcine Rotavirus VP4 Constructed Using CRISPR-Cas9D10A System Induces Effective Immunity in Mice

Co-expression of PPV VP2 and LTB on the Surface of Lactobacillus casei

The Immune Response Induced in Mice Orally Immunized with Lactobacillus Casei Expressing Porcine Parvovirus VP2 Protein

Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant

Genetic Engineering Subunit Vaccine of Group A Bovine Rotavirus

Co-expression of CSFV T Cell Epitope E290 Peptide and PPV VP2 Protein in Lactobacillus Casei and Determination of Specific Antibodies in Immunized Mice

Evaluation of the immunogenicity of auxotrophic Lactobacillus with CRISPR-Cas9D10A system-mediated chromosomal editing to express porcine rotavirus capsid protein VP4

Rotavirus VP6 protein mucosally delivered by cell wall-derived particles from Lactococcus lactis induces protection against infection in a murine model